← back to search

Arash Rafii

Cornell University · US
Area of research
Reproductive Medicine · Cancer Research
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Cancer, Hypoxia, and Metabolism, Endometrial and Cervical Cancer Treatments, and Cancer Cells and Metastasis.
h-index
41
citations
7,962
works
199
NIH funding
primary concept
email

Recent publications

Angiocrine endothelium: from physiology to cancer
Journal of Translational Medicine 2020cited by 68position: lastdoi
Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?
International Journal of Molecular Sciences 2018cited by 470position: middledoi
CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
Molecular Cancer 2018cited by 111position: middledoi
NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network
Nature Communications 2018cited by 110position: middledoi
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations
European Journal of Human Genetics 2018cited by 73position: middledoi
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
International Journal of Gynecological Cancer 2016cited by 141position: middledoi
Epithelial to Mesenchymal Transition in a Clinical Perspective
Journal of Oncology 2015cited by 94position: lastdoi
Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance
Cancer Cell 2014cited by 220position: middledoi
Endothelial Cells Provide a Notch-Dependent Pro-Tumoral Niche for Enhancing Breast Cancer Survival, Stemness and Pro-Metastatic Properties
PLoS ONE 2014cited by 83position: lastdoi
Molecular Signatures of Tissue-Specific Microvascular Endothelial Cell Heterogeneity in Organ Maintenance and Regeneration
Developmental Cell 2013cited by 607position: middledoi
Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance
Journal of Translational Medicine 2013cited by 480position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jennifer Pasquier · Weill Cornell Medical College in Qatar6 papers (2013–2020)Shahin Rafii · California Institute for Regenerative Medicine5 papers (2013–2020) · 3 papers (2013–2015) · 3 papers (2013–2020)Bi‐Sen Ding · Sichuan University2 papers (2013–2014) · 2 papers (2013–2018)Jason M. Butler · Royal Brisbane and Women's Hospital2 papers (2013–2014)Jessica Hoarau-Véchot · New York State College of Veterinary Medicine2 papers (2018–2018) · 2 papers (2013–2014)Koji Shido · Cornell University2 papers (2013–2014) · 2 papers (2018–2018) · 1 papers (2016–2016)Sharrell B. Lee · Cornell University1 papers (2014–2014)Daniel J. Nolan · The University of Texas at Austin1 papers (2013–2013)Daylon James · Cornell University1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2020–2020)Christina Fotopoulou · Imperial College London1 papers (2016–2016)Bella S. Guerrouahen · The University of Texas MD Anderson Cancer Center1 papers (2013–2013)Dean W. Felsher · Stanford Health Care1 papers (2014–2014)